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INTRODUCTION 
Regional anaesthesia is the most widely used anaesthetic technique 
for orthopaedic procedures in lower limbs
1
. Regional anaesthesia has many 
advantages over general anaesthesia as it provides a good perioperative 
pain relief, reduces systemic analgesic requirements, decreases poly 
pharmacy, avoids unnecessary airway manipulation, permits early 
ambulation and decreases chances of deep vein thrombosis.
2 
Fracture Femur is a common orthopaedic injury which causes severe 
pain and distress to the patient as the periosteum has the lowest pain 
threshold of the deep somatic structures
3
. Anaesthesia for femur surgeries 
is usually provided by subarachnoid block. Proper positioning during 
subarachnoid block is essential for a successful procedure.  However, over 
riding of bone ends during movement worsens pain, delays positioning 
which in turn increases pain further. Alleviating pain increases patient 
comfort and also provides better patient positioning for subarachnoid 
block. 
Various drugs like Non-steroidal anti-inflammatory drugs, opioids, 
midazolam, ketamine, propofol have been in use to reduce the pain pre-
operatively and improve positioning in these patients. Nerve blocks have 
come up as an effective and a safe alternative to provide pain relief . 
2 
 
Different techniques have been used to identify and block nerve 
fibres. Blockade of peripheral nerves have evolved a long way from blind 
approaches eliciting paresthesia initially, to the use of peripheral nerve 
stimulators and to the use of ultrasound off late. Earlier, nerve blocks were 
performed using landmark techniques and by eliciting paraesthesia. They 
were associated with highfailure rates and caused injury to the nerves and 
surrounding structures. Nerve stimulators were invented for higher success 
rates and to decrease the complications. It ensured a better blockade than 
conventional paraesthesia technique. But both these methods can cause 
neurovascular injuries leading to permanent nerve damage. Ultrasound is 
gaining importance in recent years and has provided anaesthesiologists, an 
effective alternative tool for the identification and safe blockade of nerve 
fibres. 
This study is designed to compare Fascia Iliaca Compartment Block 
under ultrasound guidance and  intravenous fentanyl for positioning during 
spinal anaesthesia in femur fractures. 
 
 
 
3 
 
AIM OF THE STUDY 
 
       To compare the efficacy of Fascia Iliaca Compartment Block 
under  ultrasound guidance and intravenous fentanyl for positioning during 
spinal anaesthesia in fracture femur surgeries. 
 
OBJECTIVES 
    PRIMARY OBJECTIVES: 
     To compare 
1. The analgesia obtained for positioning during spinal anaesthesia. 
2. The ease of positioning and the time taken for giving spinal 
anaesthesia 
SECONDARY OBJECTIVES: 
       To compare 
1. Hemodynamic parameters 
2. Requirement of first rescue analgesic post operatively. 
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ULTRASONOGRAPHY 
           The normal human hearing is in the range of 20 -20,000HZ. 
Ultrasound denotes sound waves with a frequency above the audible 
range.ie. more than 20,000 cycles per second.  
HISTORY OF ULTRASOUND GUIDANCE FOR NERVE BLOCKS: 
Ting and Sivagnanaratnam
4
 in 1989 were among the first to use 
ultrasonography to perform blocks. They were 100% successful with 
axillary nerve blocks and visualized the nerves around the axillary artery, 
the needle tip and the spread of local anaesthetic at all times. 
Kapral et al.
5
 in 1994 demonstrated that ultrasound guidance for 
supraclavicular blocks were safer and more effective compared to axillary 
nerve  blocks. Later in 1997, they showed that the “three-in-one” lower 
limb blocks  had a better success rate when  done using ultrasound 
compared to nerve stimulation technique
6
. The local anaesthetic 
requirement to perform an effective nerve block was also reduced under 
ultrasound guidance
7
. 
The better quality of images of brachial plexus generated by 
researchers  in Toronto with ultrasound further lead to the advancement of 
the use of ultrasound for localisation of nerves. 
5 
 
PRINCIPLE OF ULTRASONOGRAPHY
8
: 
Ultrasound uses sound waves to produce an image of structures 
through which they pass.  Ultrasound waves are emitted from piezoelectric 
crystals present in the probe of the ultrasound transducer.  When an 
electric current is applied to these crystals, they rapidly change shape and 
vibrate and emit ultrasound waves. The process converts electrical energy 
into mechanical energy and is called reverse piezoelectric effect. These 
waves travel at different rates through tissues with different densities and 
return the signal back to the transducer. The crystals convert the 
mechanical energy of the returning echoes to an electric current 
(piezoelectric effect) that is converted into a two dimensional grayscale 
image. Hence the same crystals are used to send and receive the sound 
waves.    
 
 
 
 
 
Figure-1. Mechanism of Ultrasound wave production 
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COMPONENTS OF AN ULTRASOUND MACHINE: 
Pulser  - It generates high voltage required to excite the crystals. 
Transducer - The conversion of electrical  to mechanical  energy and  
   vice versa is done by the transducer. 
Receiver - It strengthens the weak signals. 
Display - It displays the received ultrasound waves in different  
   modes. 
Memory - It keeps a record of the images and videos. 
TRANSDUCER PROBES: 
        The ideal transducer varies depending upon the depth of the target 
nerve. High frequency transducers (10 to 20 MHz) provide a high 
resolution picture  and a clear image of superficial structures  but does not 
penetrate far into tissue. A low frequency transducer (2 to 8 MHz) 
penetrates tissues better but the image produced is of low resolution. 
Hence high frequency transducers are used to image superficial structures 
and low frequency transducers are used to image deeper structures. 
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         A transducer with a linear array is mostly used for nerve imaging 
except for deeper target nerves like the sciatic nerve where a curvilinear 
transducer is preferred which maximizes the returning ultrasound waves 
and produces an optimal needle image. 
ULTRASOUND TISSUE INTERACTION
9
: 
The ultrasound waves traverse through tissues and undergo either 
REFLECTION: 
The waves are reflected back as echoes. 
REFRACTION: 
          The waves change direction after hitting an interface between two 
media with different velocities of sound transmission. 
SCATTERING: 
If the incident waves are not at right angle, then the returning echoes 
are scattered in all directions in a non-uniform manner 
ABSORPTION: 
Some of the ultrasound waves are absorbed  by the tissues and  are 
transformed to heat. 
8 
 
DIFFRACTION: 
The spreading out of the ultrasound waves as its moves further away 
from the source. 
ATTENUATION: 
The returning echoes become weaker due to absorption, scattering or 
refraction. 
 
 
 
 
 
 
Figure 2.- Ultrasound Tissue Interaction. 
ECHOGENICITY
10
: 
Echogenicity denotes the ability of a tissue to reflect ultrasound 
waves in comparison with the surrounding structures. 
HYPERECHOIC: 
        Structures which reflect more sound waves are hyperechoic. They 
appear white on the screen. Eg: bones. 
9 
 
HYPOECHOIC: 
Structures through which sound waves pass easily are called 
hypoechoic. Here the reflected sound waves are of less energy and appear 
grey on the screen. Eg: fat. 
ANECHOIC: 
                 Areas from where the sound waves are not reflected back are 
termed anechoic and appear  black on the screen. Eg: Blood vessels 
 
 
 
 
 
 
 
 
 
 
Figure-3. Echogenicity in Ultrasonography. 
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MODES OF ULTRASOUND: 
‘A’ MODE : 
           It is called ‘Amplitude Modulation” and shows amplitude spikes of 
varying  heights. It has x axis and y axis. Amplitude is displayed along the 
y axis and depth along the x axis. Mostly used in ophthalmology for optic 
nerve imaging. 
‘B’ MODE: 
It is called ‘Brightness Modulation’. This is the mode used in 
regional anaesthesia. It is based on the brightness  or the intensity of the 
echo and is two dimensional. It does not produce vertical spikes. The echo 
intensity is represented on the z axis and the depth is represented on the x 
axis. It does not have a y axis. The images are displayed either  as large 
dots which denote strong echoes or as small dots, which denote weak 
echoes. 
‘M’ MODE: 
            It is called ‘Motion Modulation’ and is used for analyzing body 
parts that are in motion. The image produced is one dimensional. Used 
mostly for imaging the heart and foetus. 
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CONTROLS IN THE MACHINE: 
GAIN-   
             It alters the intensity of the received signal. 
TIME-GAIN COMPENSATION (TGC)-  
            It differentially amplifies signals from varying depths and thus 
provides compensation for loss of signal from deeper tissues. 
FOCUS – 
The beam is adjusted so that it is narrowest at the required depth to 
image the target structure. 
DEPTH- 
Varying the depth helps to keep the target structure in the middle of 
the screen. 
ERGONOMICS : 
        The ultrasound machine is positioned on the opposite side while the 
operator stands on the ipsilateral side that has to be blocked. The USG 
monitor should always be in front of the operator so he can visualize the 
screen without any strain. Non-dominant hand is used to hold the 
transducer probe while the dominant hand is used to hold the needle. 
12 
 
PROBE ORIENTATION: 
          Transducer probes have a marker at one end. The operator has to 
orient himself as to which side of the screen corresponds to the marker on 
the probe. This will help in avoiding confusion that may arise when the 
probe is being manipulated or rotated. 
NEEDLE ADVANCEMENT APPROACHES: 
       The needle can be inserted either parallel to the ultrasound waves (in- 
plane) or not parallel ( out of plane) to the ultrasound waves. In an in-plane 
approach, the entry of the needle is at the side of the probe and the entire 
needle shaft is visualized as it approaches the target. In the out- of- plane 
approach, the entry of the needle is away from the probe and only the tip of 
the needle is seen. 
 
 
 
 
Figure-4. Needle advancement techniques  
(In-plane and Out-of-plane  approach) 
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PROBE MANIPULATION
11
: 
        Understanding of the manipulation of a transducer probe is essential 
for regional block with ultrasound. The various probe manoeuvres are 
sliding, tilting, compression, rocking and rotation. 
SLIDING: 
        Moving the transducer along the known course of the nerve helps in 
its identification. 
TILTING: 
       Tilting the probe from side to side or cross plane varies the echo 
brightness of peripheral nerves and optimising this angle promotes nerve 
visibility. 
COMPRESSION: 
              It is generally used to confirm venous structures; compression 
pushes air out of field, provides better contact and brings structures closer 
to the surface of the transducer. 
ROCKING: 
          Rocking the transducer towards or away from the indicator improves 
the visibility of the needle and anatomic structures. It helps extending the 
field of view in one direction or the other. 
14 
 
ROTATION: 
             Rotating the  probe produces true short axis view rather than 
oblique or long axis views. 
 
 
 
 
 
 
 
 
 
 
Figure-5. Ultrasound probe manipulation. 
 
ANISOTROPY: 
         It is the change in echogenicity with changes in the angle of 
incidence. Anisotropy is more for tendons but it can also occur for muscles 
and nerves.The various probe manipulations are performed in order to get 
an optimal angle of incidence which produces the best reflection of the 
target structure. 
15 
 
ADVANTAGES OF ULTRASONOGRAPHY: 
 Allows direct visualization of the nerves and their relationship to 
other structures so reduces the volume of drug needed and vascular 
injury
12
. 
 The spread of the local anaesthetic can be visualized and hence 
decreases chances of intravascular injection 
 Repositioning of the needle can be done in case of misdistribution of 
local anaesthetic. 
 Improves the quality of block. 
 Allows for patient variability and anatomic variations. 
 Avoidance of side effects due to excess dose of local anaesthetic 
 Avoidance of painful muscle contractions unlike peripheral nerve  
stimulators. 
 Nerve blocks can be done even when a patient is under  general 
anaesthesia. 
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ANATOMY OF NERVES OF LOWERLIMB
13,14 
         The four major nerves innervating the lower limb are the femoral 
nerve, lateral femoral cutaneous nerve, obturator nerve and the sciatic 
nerve. These nerves are terminal branches of the lumbosacral plexus. 
LUMBOSACRAL PLEXUS: 
           It is formed by the anterior rami of L1-L4 nerves. The anterior rami 
of L4 and L5 combine to form lumbosacral trunk which joins with anterior 
rami of S1 TO S3 to form sacral plexus. The lumbar plexus lies within the 
psoas muscle and its branches descend into the proximal thigh. 
 
 
 
 
 
Figure-6. Lumbar plexus formation. 
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FEMORAL NERVE: 
            It carries contributions from the anterior rami of L2-L4 and is the 
largest branch of the lumar plexus. 
  
 
 
 
Figure 7- Femoral Nerve course 
 
 
 
 
 
 
 
Figure 8.- Femoral Nerve relation to femoral vessels 
18 
 
COURSE: 
          It descends between the psoas major and iliacus muscle behind the 
iliac fascia and enters the thigh lateral to the femoral artery under the 
inguinal ligament. It supplies the iliacus and pectineus muscle in the 
abdomen. The nerve splits into anterior and posterior divisions in the 
femoral triangle. 
INNERVATION: 
       The anterior division gives rise to intermediate femoral cutaneous 
nerve and medial femoral cutaneous nerve which are sensory nerves.  
Nerve to Sartorius, a motor nerve is also a branch of the anterior division 
of femoral nerve.  
     The posterior division supplies the quadriceps femoris which are the 
extensors of knee.  Saphenous nerve arises from the posterior division  and 
gives sensory supply to anteromedial surface of thigh and medial part of 
lower leg, ankle and foot. 
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LATERAL FEMORAL CUTANEOUS NERVE: 
             It originates from L2 and L3. 
 
 
 
 
Figure 9.- Lateral femoral cutaneous nerve course 
COURSE:  
            It emerges from the lateral border of the psoas major muscle, then 
crosses the iliacus muscle obliquely and heads towards the anterior 
superior iliac spine. It is covered on its course by fascia iliaca. While 
passing behind the inguinal ligament, close to its lateral insertion at 
anterior superior iliac spine, the lateral femoral cutaneous nerve perforates 
fascia iliaca. 
INNERVATION: 
           The nerve splits into an anterior and posterior branch and gives 
sensory innervation to the lateral thigh. 
20 
 
OBTURATOR NERVE: 
              It  is derived from L2-L4 divisions of the lumbar plexus. 
 
 
 
 
Figure 10.-Obturator nerve course. 
 
 
 
 
 
Figure 11.- Obturator nerve in the adductor compartment. 
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COURSE: 
             It continues from its formation within the psoas major along the 
pelvic sidewall and posterior to the common iliac vessels. After passing 
over the pelvic brim, it enters the obturator canal and divides into anterior 
and posterior divisions. The psoas and pectineus muscle separate the 
obturator nerve  from the femoral nerve along its course and so obturator 
nerve is not reliably blocked by fascia iliaca compartment block. 
INNERVATION: 
               The obturator nerve supplies the adductors of  thigh; gracilis and 
pectineus. It also gives sensory innervation to the medial aspect of thigh. 
SCIATIC NERVE: 
               It arises from the anterior and posterior divisions of the anterior 
roots of L4, L5, S1, S2, S3. It supplies all the muscles below knee and also  
the muscles of the posterior compartment of thigh. The sensory innervation 
is to the entire lower leg and foot except on the medial aspect which is 
innervated by the saphenous nerve. 
         The Fascia Iliaca Compartment Block does not block the sciatic 
nerve. 
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FASCIA ILIACA
14
: 
       The fascia iliaca extends from the lower thoracic vertebrae to the 
anterior thigh. It lines the posterior abdomen and pelvis covering psoas 
major and iliacus muscle and also  forms the posterior wall of the femoral 
sheath which contains the femoral vessels. It is covered by the fascia lata 
in the femoral triangle with which it blends distally. 
ATTACHMENTS: 
 The fascia iliaca is attached laterally to the thoracolumbar fascia, 
iliac crest, anterior superior iliac spine and sartorius fascia. It is attached 
medially to the vertebral column, pelvic brim, and pectineal fascia and 
anteriorly to the  posterior part of inguinal ligament and  fascia lata. The 
space between the inguinal ligament and the hip bone is divided into a 
medial and a lateral compartment.  
          The medial compartment is called lacuna vasorum where the fascia 
iliaca forms the posterior wall of the femoral sheath. It contains the 
femoral vessels and the femoral branch of the genitofemoral nerve.  The 
lateral compartment is called lacuna musculorum where the fascia iliaca 
forms the roof and this compartment transmits the iliopsoas muscle and the 
femoral nerve. 
23 
 
         The fascia iliaca separates the lacuna musculorum from the lacuna 
vasorum with fibres that link to the capsule of the hip joint  and hence 
forms a functional septum between the two lacunae. 
. 
 
 
 
 
 
 
 
 
Figure 12.- Anatomy of Fascia Iliaca  
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FASCIA ILIACA COMPARTMENT
14 
     The Fascia Iliaca Compartment is a potential space with the following 
limits: The space is covered above by the posterior surface of fascia iliaca; 
below  by the iliacus and psoas major muscle. On the medial side, the 
space is limited by the vertebral column and is continuous craniomedially 
with the space between the quadratus lumborum muscle and its fascia. 
Craniolaterally the space  is limited by the inner lip of the iliac crest. 
 
 
 
 
 
 
Figure 13.-Fascia iliaca compartment  
25 
 
FASCIA ILIACA COMPARTMENT BLOCK
 
        Dalens et al
14
 first described the Fascia Iliaca Compartment Block on 
children using a landmark technique. It can be carried out during 
prehospital care, in emergency department and in the pre operative setting. 
It is a relatively low skill, safe and effective technique
15
 to provide 
perioperative analgesia in fracture femur patients. Ultrasound guidance 
will increase the success rate of the block.
16 
           The fascia iliaca compartment block involves, injection of the local 
anaesthetic just beneath the fascia iliaca to block the femoral and the 
lateral femoral cutaneous nerve and the obturator nerve at times.  The 
injection is done away from the femoral artery and nerve and hence the 
risk of  neurovascular complications are very low. 
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LANDMARK APPROACH
17
: 
            The inguinal ligament and the femoral pulse are identified and the 
length of the inguinal ligament is divided into thirds. A blunt tip needle is 
inserted 1cm distal to the junction between the middle and the outer thirds. 
A blunt tip needle is inserted in a slightly cephalad direction and as the 
needle passes through fascia lata and iliaca, two “pops” will be felt.  Then 
30 to 40 ml of local anaesthetic is injected after negative aspiration. 
 
 
 
 
 
Figure 14.- Fascia Iliaca Compartment block- Landmark technique 
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ULTRASOUND GUIDED APPROACH
18
: 
              The patient is placed in supine position. A high frequency linear 
ultrasound probe is placed in a horizontal direction over the anterior part of 
the  thigh just  below the inguinal ligament. The femoral artery is identified 
first. Then the iliacus muscle is identified lateral to the artery, covered by 
the fascia iliaca. The needle is then inserted either in plane or out of plane. 
The needle is advanced until the tip of the needle is placed beneath the 
fascia iliaca appreciating the pop off as the fascia is perforated. After 
negative aspiration, the local anaesthetic is injected and the spread of the 
local anaesthetic should be visible on the ultrasound machine.  
 
 
 
 
Figure 15 .- Fascia Iliaca Compartment block under USG guidance 
Probe position  
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Figure 16.-Fascia Iliaca Compartment block under USG guidance 
Needle direction 
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CLINICAL PHARMACOLOGY 
BUPIVACAINE:
19,20,21 
 
 
 
 
Figure 17.- Structural formula of Bupivacaine 
Bupivacaine(1-Butyl-N-(2,6-dimethylphenyl)piperidine-2-
carboxamide)  belongs to the amide group of local anaesthetic drugs. It 
was first synthesized  by Ekenstam in 1957 and was first used clinically by  
LJ Telivuo in 1963. Bupivacaine consists of a tertiary amine attached to a 
substituted aromatic ring by an amide linkage. The butyl group attached to 
the piperidine nitrogen makes bupivacaine more lipid soluble and potent. 
Its molecular formula is C18H29ClN2O.H2O. Its molecular weight is 
342.9. It exists as two enantiomeric forms – dextrorotary (R-) and 
levorotary (S-) .The pure levorotary form Levobupivacaine is less 
cardiotoxic. 
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MECHANISM OF ACTION: 
        Bupivacaine enters the nerve’s axon membranes and accumulate 
within the axoplasm. It binds to the alpha subunit of the voltage gated Na+ 
channels on the interior of the cell membrane, prevents channel activation 
and inhibits the sodium influx associated with membrane depolarisation. 
Local anaesthetics binding to the Na+ channel doesn’t alter the resting 
membrane potential but increases the threshold for impulse conduction 
until an action potential cannot be generated and impulse propagation is 
abolished. 
PHARMACOKINETICS: 
           Bupivacaine is a long acting, amide-type of local anaesthetic. Its 
potency and toxicity is approximately four times that of lignocaine. It 
provides long lasting sensory analgesia which outlasts the motor block 
most times. The onset and duration of action is dependent on the dose, 
concentration, route of administration and vascularity of the site of 
administration. It is used at concentrations of 0.25% to 0.5% in peripheral 
nerve blocks depending on the amount of motor blockade needed. The 
duration of action may be prolonged by adding vasoconstrictors like 
adrenaline as it decreases the rate of absorption of the local anaesthetic but 
as vasoconstriction has little impact on the duration of more hydrophobic 
agents, adrenaline is usually added to hydrophilic agents like lignocaine. 
31 
 
            Bupivacaine  is a weak base with a pKa of 8.1.At physiological pH 
of 7.4, 17% is non-ionised. It is highly protein bound (95%), and α1 acid 
glycoprotein is the most important plasma protein binding site. Its volume 
of distribution is 73 L. The elimination half-life is 210 minutes. The 
Clearance is 0.47 L/min. Bupivacaine undergoes biotransformation in liver 
by aromatic hydroxylation, N-dealkylation, amide hydrolysis, and 
conjugation.  The metabolites are excreted via the kidney. Less than 5% of 
the drug is excreted unchanged. 
USES: 
        Bupivacaine is used in local infiltration, peripheral nerve blocks, 
sympathetic nerve block, epidural and caudal block. In oral and dental 
surgery, this drug provides excellent surgical anaesthesia and extended 
post operative analgesia. 
The concentrations used are: 
     Peripheral nerve block (0.25-0.5%); Epidural Anaesthesia (0.25-0.5%); 
Spinal Anaesthesia (0.5%, 0.75%); Caudal Anaesthesia (0.25-0.5%);  
Infiltration Anaesthesia (0.25-0.5%). 
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CONTRAINDICATIONS: 
Bupivacaine is contraindicated in patients with known 
hypersensitivity reactions to it or other amide group of local anaesthetics; 
in obstetrical paracervical blocks and in intravenous regional anaesthesia 
as there is a chance of tourniquet failure which can lead to the drug being 
absorbed into systemic circulation leading to cardiac arrest.  The 0.75% 
preparation is contraindicated in epidural anaesthesia during labour as it is 
known to be associated with refractory cardiac arrest. 
ADVERSE EFFECTS: 
The  maximum dose of bupivacaine is 2-3 mg/kg. The toxic plasma 
concentration is >3mcg/ml. Toxicity can occur due to over dosage, 
accelerated absorption, intravascular injection or slow metabolic 
degradation. Toxicity is due to the blockade of the Na+ channels  on the 
excitable membranes in the brain and myocardium. Bupivacaine is 
markedly cardiotoxic. 
CNS: 
Circumoral numbness, metallic taste, restlessness, dizziness, blurred 
vision, tinnitus, disorientation, drowsiness, followed by muscle twitching, 
convulsions, unconsciousness, respiratory depression and arrest. 
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CVS: 
The marked cardiotoxicity of bupivacaine is because it binds more 
strongly and dissociates more slowly from  the Na+ channels. Toxic doses 
produce cardiac dysrhythmias, atrioventricular block, ventricular 
tachycardia and ventricular fibrillation, bradycardia and  asystole. 
TREATMENT: 
In case of toxicity, 100% oxygen is given either by face mask or 
intubation. Benzodiazepines or barbiturates like thiopentone are used for 
seizure suppression. Propofol can be used to control seizures but it may 
potentiate cardiovascular toxicity. The cardiovascular system is monitored 
and the patient has to be supported with intravenous fluids and 
vasopressors. Vasopressin has to be avoided. Rescue with 20% Intra lipid 
at a dose of 1.5 ml/kg over 1 minute. The bolus can be repeated 1- 2 times 
for persistent asystole, followed by an infusion of 0.25 ml/kg/min for 30-
60 minutes the infusion is increased up to 0.50 mL/kg/min for refractory 
hypotension. Cardiopulmonary bypass has been used effectively to treat 
cardiac arrest due to local anaesthetic toxicity. 
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FENTANYL: 
 
 
 
Figure 18.-Structural formula of fentanyl 
         Fentanyl [N-(1-(2-Phenylethyl)-4-piperidinyl)-N-phenylpropanamide 
] is a phenylpiperidine-derivative synthetic opioid agonist. It was first 
synthesized by Paul Janssen.
22,23.
  Its molecular formula is C28H36N2O8. 
The molecular weight of free base is 336.5 and that of citrate salt is 
528.59404. It is 75 to 125 times more potent as an analgesic than 
morphine. 
MECHANISM OF ACTION: 
           Fentanyl acts as an agonist at the μ-opioid receptor24 in the 
presynaptic and post synaptic sites of the central nervous system and 
outside the CNS in peripheral tissues. μ opioid receptor is responsible for 
supraspinal and spinal analgesia. Fentanyl acts by activation of the 
receptors on the primary afferent neurons. The opioid receptors are 
normally activated by three endogenous opiates namely encephalins, 
endorphins and dynorphins. Opioids mimic the actions of these 
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endogenous ligands by binding to opioid receptors and decreasing the 
neurotransmission predominantly by presynaptic inhibition of the 
neurotransmitters . 
PHARMACOKINETICS: 
       Fentanyl has a rapid onset of 5 minutes and a short duration of action 
of 30 to 60 minutes by the IV route. The rapid onset is due to its greater 
lipid solubility which easily permits its passage across the blood brain 
barrier. The short duration of action is because of its rapid redistribution 
into inactive tissues like fat and skeletal muscles and hence a decrease in 
plasma concentration. The lungs exert a significant first pass effect of upto 
75% of an injected dose of the drug. When a continuous infusion or 
multiple IV doses of fentanyl is administered, there is progressive 
saturation of these inactive tissue sites, so the plasma concentration 
increases and hence the duration of analgesia and depression of ventilation 
may be prolonged. 
            The  pKa of fentanyl is 8.4.  At Ph of 7.4, 8.5% of the drug is in 
non-ionized form. It is highly protein bound (79 to 87%). The elimination 
half time of fentanyl is 3.1-6.6 hours and is longer than that of morphine in 
spite of a short duration of action because of its larger volume of 
distribution. The Vd is 335 litres and is due to greater lipid solubility of 
fentanyl and hence more rapid passage into tissues. The plasma 
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concentrations are maintained by slow reuptake from the inactive tissue 
sites which is responsible for the persistent drug effect and the prolonged 
elimination half time. 
Fentanyl is metabolised by N-demethylation producing norfentanyl, 
hydroxyproprionyl - fentanyl and hydroxyproprionyl - norfentanyl. 
Norfentanyl  is the principal metabolite and can be detected in the urine for 
72 hours after a single IV dose. Fentanyl is a substrate for hepatic P-450 
enzymes and so there are possibilities of drug interactions
25
. Less than 
10% of fentanyl is excreted unchanged in urine. 
PREPARATIONS: 
Fentanyl is available as pills, skin patch, lozenge, a film that 
dissolves in mouth, nasal sprays and as an i.v.preparation. 
USES AND DOSAGE: 
Low doses of 1 to 2 mcg/kg IV is used to provide analgesia. It is 
used in combination with a hypnotic agent like propofol during 
anaesthesia. In procedures like endoscopy, cardiac catheterisation and oral 
surgeries, fentanyl is combined with a benzodiazepine like midazolam to 
produce sedation. It is also used in neuraxial blockade in combination with 
a local anaesthetic
24
. A dose of 2 to 20mcg/kg IV maybe given as an 
adjuvant to inhaled anaesthetics to blunt circulatory responses to 
laryngoscopy and for sudden changes in the level of surgical stimulation
26
. 
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Transmucosal preparations
27
 like lozenge mounted on a handle or 
oral transmucosal preparation are designed to deliver 5 to 20 mcg/ kg of 
fentanyl. It is used to decrease preoperative anxiety and facilitate induction 
especially in children. 
Transdermal patches
28
 delivering 75 to 100 mcg/hour are applied 
before the induction of anaesthesia and left in place for 24 hours. They 
reach peak plasma concentration in about 18 hours, tend to remain stable 
till the presence of the patch, followed by decreasing plasma concentration 
after the removal of the patch and are used for post operative analgesia. 
Intranasal fentanyl is available in doses of 50, 100 and 200mcg. The 
bioavailability is 70 to 90%. It is relatively safe with low side effects and 
used especially in children. 
ADVERSE EFFECTS: 
Persistent respiratory depression may occur as secondary peaks in 
plasma concentrations have been demonstrated. Fentanyl should be used 
with caution in the elderly, asthmatics and in COPD patients as it may 
cause hypoventilation and apnea. Other  side effects are bradycardia, chest 
wall rigidity, nausea, vomiting, drowsiness, light headedness, weakness, 
fatigue, euphoria, dry mouth, constipation, pruritus, urinary retention
24
. 
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REVIEW OF LITERATURE 
            A study conducted by Jadon et.al
29
., compared the femoral nerve 
block and intravenous fentanyl for analgesia obtained in surgery for femur 
fractures. 60 patients were divided into two groups. In one group, femoral 
nerve block was performed using a peripheral nerve stimulator with 20 ml 
of 1.5% lignocaine with adrenaline. In the other group, 1mcg/kg of 
fentanyl i.v. was given. Both these interventions were done 5 minutes 
before positioning and then both the groups received subarachnoid block. 
          In femoral nerve block group, during positioning, the visual 
analogue scale score was significantly lower (P=0.0020). The quality of 
positioning (P=0.000027) and the patient acceptance (P=0.000031) were 
significantly better when compared to intravenous fentanyl. The time 
required to perform subarachnoid block was also less in femoral nerve 
block. (P=0.000049).  
        The results showed that femoral nerve block when compared to 
intravenous fentanyl provided better analgesia for patient positioning 
during subarachnoid block in surgery for femur fractures. 
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M.J.Yun et. al.
30
, compared the analgesia obtained while 
positioning between fascia iliaca compartment block and intravenous 
alfentanil in the elderly who were posted for surgery for neck of femur 
fracture. In one group, i.v. alfentanil 10mcg/kg loading dose was given and 
then an infusion of 0.25mcg/kg/min was started 2 minutes prior to 
subarachnoid block. In the second group, fascia iliaca compartment block 
was done with 30ml of ropivacaine 20 minutes prior to subarachnoid 
block. 
The visual analogue scale score was lower (P=0.001) and the 
acceptance of the patient was better in the block group compared to 
intravenous alfentanil.  Also, the mean time taken to perform subarachnoid 
block was also significantly lower (P=0.009) in the fascia iliaca 
compartment group.  
The study showed that fascia iliaca compartment block is more 
efficient compared to intravenous alfentanil for positioning in the elderly 
who underwent subarachnoid block for neck of femur fractures. 
Lamaroon A et.al.
31
, compared femoral nerve block and 
intravenous fentanyl for analgesia to facilitate positioning in patients with 
fracture femur who underwent surgery under subarachnoid block. 64 
patients were included. Among them, 32 were given femoral nerve block, 
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fifteen minutes before spinal block with 20 ml of 0.5% bupivacaine and 
10ml of normal saline. The other 32 patients were given intravenous 
fentanyl 0.5mcg/kg initially followed by another 0.5mcg/kg five minutes 
later. Additional fentanyl 0.5mcg/kg was given in increments if the pain 
scores were above 4. Subarachnoid block was then performed in both the 
groups. 
The results obtained showed that the requirement of additional 
fentanyl, the satisfaction of positioning and the time taken to achieve 
spinal block(P=0.74) did not vary significantly between the two groups. 
Femoral nerve block and intravenous fentanyl were compared by 
SIA S.et.al.,
32 
 for analgesia during positioning in fracture shaft of femur 
surgeries done under spinal block. Patients with fracture shaft of femur 
posted for surgery under spinal block were randomized into two groups. 
One group were given femoral nerve block with 15 ml of 1.5% lidocaine 
under the guidance of a peripheral nerve stimulator while the other group 
were given 3mcg/kg of intravenous fentanyl. Spinal block was done after 5 
minutes in the sitting position in both the groups.  
The VAS scores (P<0.001), quality of patient positioning(P<0.005) 
and the acceptance of the patient (P<0.005) were comparatively better in 
the femoral nerve block group. Also, the time for performing spinal 
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anaesthesia was lesser  (P<0.05) in the femoral nerve block group 
compared to intravenous fentanyl. 
The results showed that femoral nerve block is more efficacious 
during positioning compared to intravenous fentanyl in fracture shaft of 
femur surgeries done under spinal block. 
Durrani et.al.,
33
 did a study  in patients with femur fractures posted 
for  surgery under spinal block. 84 patients were divided into two groups. 
15 minutes prior to positioning for spinal block, the FNB group received 
femoral nerve block with 15 ml of lignocaine with adrenaline and 5ml 
distilled water and the IVA group received 6mg intravenous nalbuphine.     
Visual analogue scale (VAS) during positioning was significantly less in 
FNB group (1.40±0.66) versus IVN group (3.02±1.39), P=0.000. Time 
taken to perform spinal block was significantly shorter in FNB group 
(2.15±0.78min) versus IVN (3.50±1.46min), P=0.001. Quality of patient 
positioning during spinal was significantly better in FNB group 
(2.45±0.55) than IVN group (1.88±0.80), P=0.000. Acceptance of patient 
was very significantly higher among FNB group (40/42=95.24%) than 
IVN (28/42=66.67%) group, P=0.001. 
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        Hence the results concluded that femoral nerve block provides better 
analgesia resulting in adequate positioning, rapid performance of spinal 
and higher acceptance among patients with femoral fracture during 
positioning for administration of spinal anaesthesia. 
            Singh AP. et.al.,
34
 conducted a comparative study in patients who 
underwent femur surgery under combined spinal epidural block. 30 
patients in Group I  were given FNB using nerve stimulator with 0.2% 
ropivacaine (15 ml) and in 30 patients in Group II, i.v. fentanyl 0.5 mcg/kg 
was given as preemptive analgesia. 
           VAS at 2 min in Group I was 5.63 and in Group II it was 8.00. 
Satisfaction score was better in Group I as compared to Group II patients. 
Time to administer subarachnoid block was 17.80 min in patients of Group 
I as compared to 25.03 min in Group II patients. Postoperatively, VAS 
scores were lower in Group I than Group II patients. The frequency of 
epidural top‑ups was higher in Group II than in Group I patients. 
             FNB is comparatively better in comparison to I.V. fentanyl when 
used as preemptive and postoperative analgesic in patients being operated 
for fracture femur. 
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               Kumar D. et. Al
35
 performed a study in 50 patients undergoing 
surgery for hip fracture. All 50 patients received an USG guided Fascia 
Iliaca Compartment Block (FICB) in the premedication room with 30 mL 
of 0.5% ropivacaine by 23G spinal needle. Sensory blockade was 
evaluated at  5, 10 and 20 minutes after giving  ropivacaine using loss of 
perception to cold in the lateral, anterior and medial part of the thigh. 
Visual analogue scale scores were noted before the block, 20 minutes after 
block and during positioning for spinal anaesthesia. Patient’s acceptance 
for FICB was evaluated 24 hour after arriving back to the orthopaedics 
ward using a two point score. 
             In lateral part of thigh, at 5 minutes sensory blockade was present 
in 33 patients (66%) and at 10 minutes sensory blockade was present in 45 
cases (90%). In anterior part of thigh, sensory blockade was present in 34 
cases (68%) at 5 minutes time interval and at 10 minutes sensory blockade 
was present in 48cases (96%). In medial part of thigh, 28 cases (56%) had 
sensory blockade at 5 minutes and at 10 minutes in 43 cases (86%). 
Sensory blockade was same at 20 minutes as on 10 minutes interval in all 
thigh parts. 
 
44 
 
           Before FIC block average VAS was 7.5 which was decreased to 
average of 2.94 at 20 minutes after block which was statistically significant 
(p<0.01). During positioning for spinal anaesthesia, 46 patients had VAS 
less than 4. Positioning during spinal anaesthesia was assessed 
unsatisfactory in 2 cases, satisfactory in 5 cases, good in 25 cases and 
excellent  in 18 cases. 
It was concluded that Ultrasound guided FICB can be performed 
safely without complications in controlling pain for patients with hip 
fracture. 
            Dureja et.al.,
36
 conducted a study in  60 cases  with suspected 
fracture femur . The patients were randomized in two groups to receive 
fascia illiaca compartment block or intramuscular diclofenac sodium. 
Group F patients (n=30) received FICB with 0.5% bupivacaine (0.4ml/ kg 
ideal body weight diluted with 0.9% saline to make a total amount 40 
ml)by landmark technique.  Group D patients received 75 mg diclofenac 
sodium intramuscularly. The results were compared in terms of VAS score 
at rest and after 15 degrees hip flexion and the duration of analgesia post-
procedurally. 
 
45 
 
           The VAS scores before the procedure at rest (median values)were 
statistically comparable in both the group i.e. 8 (7-8) in FICB and 7.5 (7-8) 
in diclofenac group (p=0.756). After 10 minutes of intervention, the 
median VAS score was same in both the groups i.e. 7 (p=0466). After 20 
minutes, in group F, median VAS score was 3 (2-3) and 5 (5-6.2) in 
diclofenac group. There was a statistically significant difference when 
these groups were compared (P=0.01). After 30 minutes the VAS score 
was 2 (1-2) in group F and 3 (1.8-3.6) in group D with P-value <0.01. 
After 60 minutes, median VAS score for group F was 1 (1-1.3) and 3 (2-3) 
for group D with P<0.01. Pain assessed by VAS score with passive hip 
flexion before the procedure was same in both the groups i.e. (8-9). After 
30 minutes, it was 2 (2-3) in group F and 6 (5-7) in group D. The 
difference was a statistically significant when these groups were compared 
(P <0.01). The duration of analgesia was significantly longer in group F 
than diclofenac group when both the groups were statistically compared 
 P <0.01  
             It was concluded that pain following fracture of femur can be 
managed more effectively using  fascia illiaca block with minimal 
discomfort. 
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Foss NB et.al.,
37
 did a study comparing the analgesia obtained 
between fascia iliaca compartment block and i.m. morphine in hip 
fractures. 48 patients were allocated into 2 groups. One group were given 
fascia iliaca compartment block with 1% mepivacaine while the other 
group were given 0.1mg/kg i.m. morphine. Intravenous morphine was used 
as rescue analgesic. The results obtained showed that the analgesia 
obtained was higher in the block group at rest (P<0.01) and on movement. 
(P=0.02). 
          Lopez et.al.,
38 
 conducted a study to assess the analgesia obtained 
with fascia iliaca compartment block in femur fractures in pre-hospital 
care. In 27 patients,  fascia iliaca compartment block was done with 20 ml 
of 1.5% lidocaine with adrenaline using landmark technique. The 
simplified verbal score was significantly lower (P<0.05) before the block, 
10 minutes later and on arrival at the trauma care center. 
         The study concluded that fascia iliaca compartment block provides 
effective preoperative analgesia in femur fractures. 
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MATERIALS AND METHODOLOGY 
 
60 patients posted for femur surgeries at Government Kilpauk 
Medical College Hospital and Government Royapettah hospital from 
February 2016 to July 2016 were assessed for the inclusion and exclusion 
criteria and were included in the study after obtaining written informed 
consent. 
SAMPLE SIZE CALCULATION: 
Sample size was determined based on  
Study : 
Comparative evaluation of femoral nerve block and intravenous fentanyl 
for positioning during spinal anaesthesia in surgery of femur fracture 
Authored by : 
Ashok Jadon,et al
29 
Published in: 
Indian Journal of Anaesthesia | Vol. 58 | Issue 6 | Nov-Dec 2014 
       In this study time to perform spinal anesthesia in group FNB: 15.33 ± 
1.64 min versus FENT 19.56 ± 3.09 min (P = 0.000049) with a standard 
deviation of 3.09 
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Description: 
         The formula for determining sample size is given as: 
 
Where n = Sample size 
σ = Population standard deviation 
e = Margin of error 
Z = The value for the given confidence interval 
•The confidence level is estimated at 95% 
•Standard deviation 3.09 
•With a z value of 1.96 
•The confidence interval or margin of error is estimated at +/-0.80 
• Assuming that 80 percent as power of the study, minimum sample size 
required for the study was calculated to be 58. 
In our study 60 subjects were chosen  
(n=30 in FICB arm and n=30 in Fentanyl arm) 
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STUDY DESIGN: 
Prospective,  Randomized,  single-blind,  Controlled study. 
INCLUSION CRITERIA: 
1)  Patients belonging to ASA grade I and II. 
2)  Patients of either sex, between the age group 18 to 55 years. 
3)  Patients with fracture femur, posted for surgery under sub-arachnoid 
block. 
4)  Patients who give a valid informed consent. 
EXCLUSION CRITERIA: 
1)  Patients not satisfying inclusion criteria. 
2)  Patients belonging to ASA grade III or IV. 
3)  Patients with hemorrhagic diathesis, neurological disorders, 
psychiatric disorders. 
4)  Previous femoral bypass surgery. 
5)  Patients with allergy to local anaesthetics or opioids. 
6)  Patients with polytrauma, infection over the injection site. 
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7)  Patients on previous opioid therapy. 
8)  Morbid obesity. 
9)  Patients who will be administered with supplementary epidural or 
general anaesthesia. (In patients with prolonged surgeries when 
conversion is required). 
10)  Patients with spinal deformities. 
11)  Patients who decline consent  
12)  Patients with language barrier. 
MATERIALS: 
1)  Boyle’s machine 
2)  Laryngoscope with different blade sizes 
3)  Endotracheal tubes 
4)  Other airway gadgets used in case of difficult intubation 
5)  Mind Ray ultrasound machine with linear transducer probe 
6)  Ultrasound jelly 
7)  Sterile tray with sterile towel, gauze packs, sponge holding forceps 
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8)  Disposable 10ml, 5ml syringes, sterile gloves 
9)  18G venflon needle for Fascia Iliaca Compartment Block 
10) 25 G Quincke needle for sub arachnoid block 
DRUGS: 
1)  Bupivacaine 0.5% available as 20ml vial 
2)  Inj. Fentanyl available as 2ml ampoule 
3)  Preservative free bupivacaine available as 4 ml ampoule for spinal 
block 
4)  Emergency drugs needed for resuscitation 
5)  Distilled water. 
MONITORS: 
NIBP 
ECG 
Pulse Oximeter 
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METHODOLOGY: 
          Patients satisfying the inclusion criteria were selected, counselled 
about the risks and benefits involved in the study. After obtaining informed 
consent, patients who were willing to be included in the study were 
enrolled. They were preoperatively evaluated, clinically examined and 
assessed. A total of 60 patients were included in the study. They were 
randomly allocated into two groups. 
 Group FICB : were administered ultrasound guided Fascia Iliaca 
Compartment Block  preoperatively. 
        Group FENT: were administered intravenous fentanyl preoperatively. 
 All patients were kept nil per oral for atleast 6 hours before the 
procedure. Patients were shifted inside the operation theatre half an hour 
before the scheduled procedure. Baseline vitals such as pulse rate, non-
invasive blood pressure, saturation in room air, respiratory rate, ECG 
pattern were recorded. Intravenous access was obtained with 18G IV 
cannula and IV fluid started. Local anaesthetic test dose was given using 
0.1 ml of Inj. Lignocaine 2%. All patients  were  premedicated with 
Inj.Ondansetron 0.1mg/kg intravenously. Oxygen was given via Hudson's 
mask @ 4 lit/min. 
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         Group FICB patients were placed in supine position. The local 
anaesthetic solution was prepared with 15 mL of 0.5% bupivacaine and 
15ml of distilled water and hence 30ml of 0.25% bupivacaine. The 
Ultrasound Machine was powered on and the linear array probe was 
covered with sterile dressing after applying ultrasound gel. The probe was 
placed in a horizontal direction over the anterior part of thigh just below 
the inguinal ligament. The ultrasound setting used to visualise was at a 
frequency of 10 MHz and a depth of 3-4cm. The gain and focus were 
adjusted according to the image scanned. Femoral artery was identified 
first .Then the iliacus muscle covered by fascia iliaca was identified lateral 
to the artery. An 18G needle was then inserted in plane to the ultrasound 
beam. The needle was advanced until the tip of the needle was placed 
beneath the fascia iliaca (appreciating the give as the fascia is perforated) 
and after negative aspiration, the local anaesthetic was injected and its 
spread visualized on the ultrasound screen. The fascia iliaca compartment 
block was done 15 minutes before the sub arachnoid block. 
            Group FENT patients received titrated doses of  Inj.Fentanyl 
0.5mcg/kg I.V. repeated to 3 doses (1.5 mcg totally) with an interval of 5 
minutes between doses. 
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 Hemodynamic variables like heart rate, non invasive blood pressure, 
saturation of oxygen, respiratory rate were recorded after the block/ 
iv fentanyl and at five minutes intervals till positioning . 
 The analgesia provided by either of the modes was assessed by 
using Visual analogue scale scores 15 minutes(ie. during 
positioning)  after the block/ I.V. Fentanyl. 
 
 
 
 
Figure 19.- Visual Analogue Scale score 
 Sub arachnoid block was performed in the sitting posture under 
strict aseptic precautions in the L3-L4 space using 25G Quincke 
needle with 3ml of 0.5%Bupivacaine (hyperbaric, dextrose 
80mg/ml)+0.5ml(50mcg) of fentanyl. 
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 The quality of patient positioning for administering spinal 
anaesthesia was recorded by another anaesthesiologist blinded to the 
mode of analgesia with scores of 0-3
32
. 
0-Not satisfactory 
1-satisfactory 
2-good                   
3-optimal 
 Time to perform spinal anaesthesia will be recorded (time from 
beginning of positioning to end of spinal)
32
. 
 Patient satisfaction was also recorded 
          1- satisfactory   
2- not satisfactory 
 Post-operative analgesia was standardized in all patients of both 
groups with Inj.Tramadol 50 mg I.V. 8th hourly; first dose was given 
whenever patient complained of pain. 
      The collected data were recorded for further statistical analysis. 
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OBSERVATION AND RESULTS 
 
GROUPS: 
 
GROUP INTERVENTION NUMBER 
FICB Group  
Fascia Iliaca 
Compartment Block 
30 
FENT Group   Intravenous fentanyl 30 
 
NULL HYPOTHESIS : 
 
Null Hypothesis : H0  
 
Fascia iliaca compartment block with 
bupivacaine is equal in effect to intravenous 
fentanyl for positioning in patients undergoing 
spinal anaesthesia in fracture femur surgery 
Alternate Hypothesis 
: H1  
Fascia iliaca compartment block with 
bupivacaine is better in effect to intravenous 
fentanyl for positioning in patients undergoing 
spinal anaesthesia in fracture femur surgery 
 
DATA ANALYSIS: 
 
         Descriptive statistics was done for all data and were reported in terms 
of mean values and percentages. Suitable statistical tests of comparison 
were done. Continuous variables were analyzed with the unpaired t test.. 
Categorical variables were analyzed with the Chi-Square Test and Fisher 
Exact Test. Statistical significance was taken as P < 0.05. The data was 
analyzed using SPSS version 16 and Microsoft Excel 2007. 
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AGE: 
 
 
 
Age - 
Groups 
FICB 
Group 
% 
FENT 
Group 
% 
21-30 years 5 16.67 4 13.33 
31-40 years 2 6.67 2 6.67 
41-50 years 9 30.00 12 40.00 
51-60 years 14 46.67 12 40.00 
Total 30 100 30 100 
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Age Distribution FICB Group FENT Group 
N 30 30 
Mean 46.07 45.53 
SD 10.76 9.27 
P value   
Unpaired t Test 
0.8378 
 
       Among the patients undergoing spinal anaesthesia in fracture femur 
surgery, there was no statistically significant difference in relation to age 
distribution between FICB group (mean=46.07, SD=10.76) and FENT 
group (mean=45.53, SD=9.27) with a p value of >0.05 as per unpaired t 
test. Therefore we fail to reject the null hypothesis that there is no 
difference in age distribution between the intervention groups. 
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GENDER:  
 
 
 
Gender - 
Groups 
FICB Group % 
FENT 
Group 
% 
Male 19 63.33 20 66.67 
Female 11 36.67 10 33.33 
Total 30 100 30 100 
P value  
Chi Squared Test 
0.7866 
 
        Among the patients undergoing spinal anaesthesia for fracture femur 
surgery, there was no statistically significant difference in relation to 
gender status between FICB group (male-63.33%, female-36.67%) and 
FENT group (male-66.67%, female-33.33%) with a p value of >0.05 as per 
chi squared test. Therefore we fail to reject the null hypothesis that there is 
no difference in gender status between the intervention groups. 
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WEIGHT: 
 
 
 
Weight - 
Groups 
FICB 
Group 
% 
FENT 
Group 
% 
51-60 kg 14 46.67 11 36.67 
61-70 kg 15 50.00 17 56.67 
71-80 kg 1 3.33 2 6.67 
Total 30 100 30 100 
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Weight Distribution FICB Group FENT Group 
N 30 30 
Mean 62.77 63.20 
SD 5.46 5.10 
P value   
Unpaired t Test 
0.7520 
 
          Among the patients undergoing spinal anaesthesia in fracture femur 
surgery, there was no statistically significant difference in relation to 
weight distribution between FICB group (mean=62.77, SD=5.46) and 
FENT group (mean=63.20, SD=5.10) with a p value of >0.05 as per 
unpaired t test. Therefore we fail to reject the null hypothesis that there is 
no difference in weight distribution between the intervention groups. 
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NUMBER OF DAYS SINCE FRACTURE: 
 
 
 
Number of Days Since 
Fracture - Groups 
FICB 
Group 
% 
FENT 
Group 
% 
1-2 days 2 6.67 3 10.00 
3-4 days 14 46.67 10 33.33 
5-6 days 11 36.67 14 46.67 
7-8 days 3 10.00 3 10.00 
Total 30 100 30 100 
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Number of Days Since 
Fracture 
FICB Group FENT Group 
N 30 30 
Mean 4.53 4.67 
SD 1.50 1.54 
P value  
Unpaired t Test 
0.7354 
 
      Among the patients undergoing spinal anaesthesia in fracture femur 
surgery, there was no statistically significant difference in relation to 
duration since fracture distribution between FICB group (mean=4.53, 
SD=1.50) and FENT group (mean=4.67, SD=1.54) with a p value of >0.05 
as per unpaired t test. Therefore we fail to reject the null hypothesis that 
there is no difference in duration since fracture distribution between the 
intervention groups. 
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VAS DURING POSITIONING: 
 
 
 
VAS During 
Positioning - 
Groups 
FICB 
Group 
% 
FENT 
Group 
% 
VAS 0 15 50.00 5 16.67 
VAS 2 13 43.33 18 60.00 
VAS 4 2 6.67 5 16.67 
VAS 6 0 0.00 2 6.67 
Total 30 100 30 100 
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VAS During Positioning FICB Group FENT Group 
N 30 30 
Mean 1.13 2.27 
SD 1.25 1.55 
P value  
Unpaired t Test 
0.0029 
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Among the patients undergoing spinal anaesthesia in fracture femur 
surgery, there was a statistically significant difference in relation to VAS 
score during positioning between FICB group (mean=1.13, SD=1.25) and 
FENT group (mean=2.27, SD=1.55) with a p value of <0.05 as per 
unpaired t test. Therefore we reject the null hypothesis that there is no 
difference in VAS score during positioning distribution between the 
intervention groups. 
The mean VAS score during positioning was significantly lesser in 
FICB group compared to FENT group by a mean difference of 1.13 
scoring points (50% lesser). This difference is significant with a p-value of 
0.0029 as per unpaired t-test.  
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QUALITY OF PATIENT POSITIONING:
 
0- NOT SATISFACTORY 
1- SATISFACTORY 
2- 2-GOOD 
3- OPTIMAL 
QOP 
Positioning – 
Groups 
FICB 
Group 
% 
FENT 
Group 
% 
QOPP 0 0 0.00 2 6.67 
QOPP 1 2 6.67 5 16.67 
QOPP 2 13 43.33 18 60.00 
QOPP 3 15 50.00 5 16.67 
Total 30 100 30 100 
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Quality of Patient 
Positioning 
FICB Group FENT Group 
N 30 30 
Mean 2.43 1.87 
SD 0.63 0.78 
P value  
Unpaired t Test 
0.0024 
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Among the patients undergoing spinal anaesthesia in 
fracture femur surgery, there was a statistically significant 
difference in relation to quality of patient positioning between 
FICB group (mean=2.43, SD=0.63) and FENT group 
(mean=1.87, SD=0.78) with a p value of <0.05 as per unpaired t 
test. Therefore we reject the null hypothesis that there is no 
difference in quality of patient positioning distribution between 
the intervention groups. 
The mean quality of patient positioning score was 
significantly higher in FICB group compared to FENT group by 
a mean difference of 0.57 scoring points (23% higher). This 
difference is significant with a p-value of 0.0024 as per unpaired 
t-test.  
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PATIENT SATISFACTION: 
 
 
 
1-SATISFACTORY 
2- N0T SATISFACTORY 
 
Patient 
Satisfaction - 
Groups 
FICB 
Group 
% 
FENT 
Group 
% 
Yes 29 96.67 23 76.67 
No 1 3.33 7 23.33 
Total 30 100 30 100 
P value 
Fishers Exact Test 
0.0284 
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    Among the patients undergoing spinal anaesthesia in fracture 
femur surgery, there was a statistically significant difference in 
relation to patient satisfaction status between FICB group 
(yes=96.67%, no=3.33%) and FENT group (yes=76.67%, 
no=23.33%) with a p value of <0.05 as per unpaired t test. 
Therefore we reject the null hypothesis that there is no difference 
in patient satisfaction status between the intervention groups. 
         The positive patient satisfaction status was significantly 
higher in FICB group compared to FENT group by a percentage 
difference of 20.00 (21% higher). This difference is significant 
with a p-value of 0.0284 as per Fisher’s exact test.  
 
 
 
 
 
 
 
 
 
 
 
 
72 
 
TIME TO PERFORM SAB: 
 
 
 
Time to 
Perform SAB - 
Groups 
FICB 
Group 
% 
FENT 
Group 
% 
≤ 5.00 mins 17 56.67 3 10.00 
5.01-6.00 mins 13 43.33 16 53.33 
6.01-7.00 mins 0 0.00 8 26.67 
7.01-8.00 mins 0 0.00 3 10.00 
Total 30 100 30 100 
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Time to Perform SAB FICB Group FENT Group 
N 30 30 
Mean 4.90 5.86 
SD 0.55 0.83 
P value  
Unpaired t Test 
<0.0001 
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Among the patients undergoing spinal anaesthesia in 
fracture femur surgery, there was a statistically significant 
difference in relation to time to perform subarachnoid block 
between FICB group (mean=4.90, SD=0.55) and FENT group 
(mean=5.86, SD=0.83) with a p value of <0.05 as per unpaired t 
test. Therefore we reject the null hypothesis that there is no 
difference in time to perform subarachnoid block distribution 
between the intervention groups. 
The mean time to perform subarachnoid block was 
significantly shorter in FICB group compared to FENT group by 
a mean difference of 58 seconds (16% shorter). This difference is 
significant with a p-value of <0.0001 as per unpaired t-test.  
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HEART RATE: 
 
 
 
Heart Rate (beats 
per min) 
Before 
Block 
5 mins 
10 
mins 
15 mins 
(During 
Positioning) 
FICB 
Group 
Mean 86.93 87.67 86.90 86.13 
SD 8.77 8.18 8.41 8.44 
FENT 
Group 
Mean 88.70 85.63 82.37 79.67 
SD 7.55 7.29 7.19 7.13 
P value  
Unpaired t Test 
0.4065 0.3138 0.0287 0.0022 
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Among the patients undergoing spinal anaesthesia in 
fracture femur surgery, there was a statistically significant 
difference in relation to heart rate at 10 -15 minutes between 
FICB group (mean=86.52, SD=8.39) and FENT group 
(mean=81.02, SD=7,10) with a p value of <0.05 as per unpaired 
 t test. Therefore we reject the null hypothesis that there is no 
difference in heart rate distribution at (10-15 mins) between the 
intervention groups. 
The mean heart rate was significantly lower in FENT group 
compared to FICB group by a mean difference of 6 bpm (6% 
lower). This difference is significant with a lowest p-value of 
0.0022 as per unpaired t-test.  
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MEAN ARTERIAL PRESSURE: 
 
 
 
Mean Arterial 
Pressure 
(mm Hg) 
Before 
Block 
5 mins 
10 
mins 
15 mins 
(During 
Positioning) 
FICB 
Group 
Mean 100.17 99.83 98.20 97.73 
SD 7.34 5.97 6.06 5.61 
FENT 
Group 
Mean 101.87 100.80 99.20 98.17 
SD 6.77 5.77 5.36 5.56 
P value  
Unpaired t Test 
0.3548 0.5262 0.5010 0.7649 
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Among the patients undergoing spinal anaesthesia in 
fracture femur surgery, there was no statistically significant 
difference in relation to mean arterial pressure between FICB 
group (mean=98.98, SD=5.96) and FENT group (mean=100.01, 
SD=5.75) with a p value of >0.05 as per unpaired t test. 
Therefore we fail to reject the null hypothesis that there is no 
difference in mean arterial pressure distribution between the 
intervention groups. 
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SPO2: 
 
 
 
Peripheral Capillary 
Oxygen Saturation 
(%) 
Before 
Block 
5 mins 
10 
mins 
15 mins 
(During 
Positioning) 
FICB 
Group 
Mean 98.03 98.73 99.13 99.27 
SD 0.76 0.69 0.63 0.52 
FENT 
Group 
Mean 98.10 98.97 99.17 98.94 
SD 0.76 0.67 0.70 0.89 
P value  
Unpaired t Test 
0.7359 0.1892 0.8467 0.1118 
 
98 
99 
99 
99 
98 
99 
99 
99 
97
98
98
99
99
100
Before Block 5 mins 10 mins 15 mins (During
Positioning)
M
e
an
 V
al
u
e
s 
Peripheral Capillary Oxygen Saturation 
(%) 
FICB Group FENT Group
80 
 
Among the patients undergoing spinal anaesthesia in 
fracture femur surgery, there was no statistically significant 
difference in relation to peripheral capillary oxygen saturation 
between FICB group (mean=98.79, SD=0.51) and FENT group 
(mean=98.71, SD=0.65) with a p value of >0.05 as per unpaired t 
test. Therefore we fail to reject the null hypothesis that there is no 
difference in peripheral capillary oxygen saturation distribution 
between the intervention groups. 
 
 
 
 
 
 
 
 
 
 
 
81 
 
RESPIRATORY RATE: 
 
 
 
Respiratory Rate  
(breaths per min) 
Before 
Block 
5 mins 10 mins 
15 mins 
(During 
Positioning) 
FICB 
Group 
Mean 17.40 17.40 17.17 16.70 
SD 1.38 1.19 0.91 1.12 
FENT 
Group 
Mean 17.33 16.97 15.57 14.57 
SD 0.96 1.16 1.17 1.48 
P value  
Unpaired t Test 
0.8287 0.0873 <0.0001 <0.0001 
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Among the patients undergoing spinal anaesthesia in 
fracture femur surgery, there was a statistically significant 
difference in relation to respiratory rate at (10 -15 minutes) 
between FICB group (mean=16.93, SD=0.93) and FENT group 
(mean=15.07, SD=1.27) with a p value of <0.05 as per unpaired t 
test. Therefore we reject the null hypothesis that there is no 
difference in respiratory rate distribution (10-15 mins) between 
the intervention groups. 
The mean respiratory rate was significantly lower in FENT 
group compared to FICB group by a mean difference of 2 breaths 
per minute (11% lower). This difference is significant with a 
lowest p-value of <0.0001 as per unpaired t-test.  
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FIRST RESCUE ANALGESIC POSTOPERATIVE: 
 
 
 
 
First rescue 
analgesic 
Postoperative - 
Groups 
FICB 
Group 
% 
FENT 
Group 
% 
≤ 3.00 hrs 0 0.00 30 100.00 
3.01-5.00 hrs 3 10.00 0 0.00 
5.01-7.00 hrs 26 86.67 0 0.00 
7.01-9.00 hrs 1 3.33 0 0.00 
Total 30 100 30 100 
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First Rescue Analgesic 
Postoperative 
FICB 
Group 
FENT 
Group 
N 30 30 
Mean 5.90 1.65 
SD 0.80 0.60 
P value  
Unpaired t Test 
<0.0001 
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Among the patients undergoing spinal anaesthesia in 
fracture femur surgery, there was a statistically significant 
difference in relation to time of first postoperative analgesic need 
between FICB group (mean=5.90, SD=0.80) and FENT group 
(mean=1.65, SD=0.60) with a p value of <0.05 as per unpaired t 
test. Therefore we reject the null hypothesis that there is no 
difference in time of first postoperative analgesic need between 
the intervention groups. 
The mean time of first postoperative analgesic need was 
significantly delayed in FICB group compared to FENT group by 
a mean difference of 4 hours and 15 minutes (72% more 
delayed). This difference is significant with a p-value of <0.0001 
as per unpaired t-test.  
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DISCUSSION 
Spinal anaesthesia is the most commonly used anaesthetic technique 
of choice in orthopaedics for lower limb fractures. While regional 
anaesthesia has been shown to be more beneficial compared to general 
anaesthesia, patient positioning for neuraxial blockade may cause severe 
pain in patients with femur fractures. Various systemic analgesics are 
being used to provide pain relief during positioning in these patients. 
Among the systemic analgesics, opioids are widely used but they are 
known to be associated with side effects like cognitive impairment, 
vomiting, urinary retention , respiratory depression especially in the 
elderly. Nerve blocks  like the 3 in 1 block, femoral nerve block, fascia 
iliaca compartment block
 
have all come up as an alternative approach to 
provide pain relief and improve positioning in these patients
39,40
. 
Fascia iliaca compartment block, first described by Dalens et al is a 
simple, low skill and safe technique that can be used during prehospital 
care, emergency department and in the pre operative setting
41
.  It blocks 
the femoral, lateral femoral cutaneous nerve and sometimes the obturator 
nerve. Also, since the injection is done away from the artery and nerve, 
there are minimal chances of neurovascular injury
42
. The usage of 
ultrasound guidance to visualize the fascia iliaca and to deposit the drug 
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beneath it lateral to the femoral nerve increases the success rate of block 
and further reduces the risk of neurovascular injury.  
In this prospective, randomized study, the efficacy of fascia iliaca 
compartment block under ultrasound guidance with bupivacaine was 
compared with intravenous fentanyl for positioning during spinal 
anaesthesia in femur fractures. 60 patients satisfying the inclusion criteria 
were chosen and divided into two groups of thirty each. Group FICB 
received 30ml of 0.25% bupivacaine  under ultrasound guidance fifteen 
minutes before positioning, while group FENT received titrated doses of 
Inj. Fentanyl 0.5mcg/kg I.V. repeated to 3 doses (1.5 mcg totally) with an 
interval of 5 minutes between doses the first dose given 15 minutes before 
positioning. 
The mean age was 46.07 ±10.76 in FICB group and 45.53 ±9.27 in 
FENT group The sex distribution in FICB group was 19 males and 11 
females while in FENT group, there were 20 males and 10 females. The 
mean weight in FICB group was 62.77 ±5.46 while in FENT group it was 
63.20 ±5.10. Thus both the groups were comparable in terms of age, sex 
and weight distribution as the P value was not significant. (P>0.05). The 
duration since fracture to surgery was (FICB- 4.53±1.50 days; FENT-
4.67±1.54) was comparable too. (P>0.05) 
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The Visual Analogue Scale score during positioning was 1.13 ±1.25 
in FICB group and 2.27±1.55 in FENT group and was statistically 
significant with a P value of 0.0029. It shows that fascia iliaca 
compartment block provides better analgesia for patient positioning in 
fracture femur surgeries. 
A time interval of fifteen minutes before the block/iv fentanyl was 
chosen as the onset of action of bupivacaine is 5 to 10  minutes
43
.  The 
analgesic dose of fentanyl is 1-2 mcg/kg i.v and the peak plasma 
concentration of fentanyl occurs at 6-7 minutes.
44,45
 The time interval 
allows titration of the dose of fentanyl which reduces possibility of side 
effects like hypoventilation or apnea. The analgesic effect of bupivacaine 
may be maximised by increasing the time interval since block. 
The quality of patient positioning was higher in FICB group with a 
mean of 2.43±0.63 when compared to FENT group which had a mean of 
1.87±0.78. It was statistically significant with a P value of 0.0024. It 
means that fascia iliaca compartment block provides better quality of 
patient positioning for spinal anaesthesia compared to i.v. fentanyl. Patient 
satisfaction was also significantly better in FICB group (P=0.0284). 
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The time taken to perform subarachnoid block (time from beginning 
of positioning to end of spinal) was shorter in FICB group 4.90±0.55 
compared to FENT group 5.86±0.83. It was statistically significant with a 
P value of <0.0001. It indicates that FICB reduces the time taken for 
providing  subarachnoid block. 
The heart rate was significantly lower in FENT group at 10 and 15 
minutes (P<0.05) while there was no significant difference in MAP and 
oxygen saturation between the two groups. The respiratory rate was 
significantly less in FENT group at 10 and 15 minutes (P<0.0001) though 
none of the patients had a respiratory rate of < 12/minute or a saturation  
of < 95%. 
FICB had the advantage of significant post op analgesia as the 
requirement of first rescue analgesic was after 5.90±0.80 hrs compared to 
1.65±0.60 hrs in FENT group. ( P<0.0001). 
There were no complications of block like infection, block failure, 
vascular puncture , nerve damage
46
  or systemic toxicity of bupivacaine. 
In this study, Fascia Iliaca Compartment  Block  proved to be more 
advantageous than i.v. fentanyl to facilitate patient positioning in femur 
fractures. Fascia Iliaca Compartment Block could also  be more useful in 
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procedures like placing an epidural or in patients with spinal abnormalities 
where the patients may have to be in a sitting position for a longer time. 
Also, the placement of a catheter in the fascia iliaca compartment and 
inclusion of additives would further increase the duration of post op 
analgesia. 
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SUMMARY 
AIM: 
To compare the efficacy of Fascia Iliaca Compartment Block under  
ultrasound guidance  and intravenous fentanyl for positioning during spinal 
anaesthesia in fracture femur surgeries. 
OBJECTIVES: 
PRIMARY OBJECTIVES: 
     To compare 
1. The analgesia obtained for positioning during spinal anaesthesia. 
2. The ease of positioning and the time taken for giving spinal 
anaesthesia 
SECONDARY OBJECTIVES: 
       To compare 
1. Hemodynamic parameters 
2. Requirement of first rescue analgesic post operatively 
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      60 patients satisfying the inclusion criteria were chosen and divided 
into two groups of thirty each. 
 Group FICB received 30ml of 0.25% bupivacaine under ultrasound 
guidance fifteen minutes before positioning.  
Group  FENT received titrated doses of Inj.Fentanyl 0.5mcg/kg I.V. 
repeated to 3 doses (1.5 mcg totally) with an interval of 5 minutes between 
doses the first dose given 15 minutes before positioning. 
It was interpreted that, 
1. Fascia Iliaca Compartment Block provided superior analgesia 
compared to i.v. fentanyl for positioning during spinal anaesthesia. 
2. The quality of patient positioning and the satisfaction of the patient 
were better in Fascia Iliaca Compartment Block. 
3. The time taken to perform subarachnoid block was lesser in Fascia 
Iliaca Compartment Block compared to I.V. fentanyl. 
4. Fascia Iliaca Compartment Block provided better  post op analgesia 
compared to i.v. fentanyl. 
93 
 
CONCLUSION 
 
It is concluded that Fascia Iliaca Compartment Block is more 
efficacious than intravenous fentanyl for positioning during spinal 
anaesthesia in surgery for fracture femur. Fascia Iliaca Compartment Block  
provides superior analgesia, better quality of patient positioning, greater 
patient satisfaction thereby reducing the time taken to perform spinal 
anaesthesia in sitting position compared to i.v. fentanyl in fracture femur 
surgery.  
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PROFORMA 
Name :                                                     
Age/sex :                                
Ip no  : 
History: 
No. Of days since fracture: 
Co morbids: 
History of previous surgeries: 
Drug history: 
Pre operative Examination: 
     Weight:                                   
      Pulse rate: 
      Blood pressure: 
      Respiratory rate: 
      Spo2 at room air: 
      Cardio vascular system: 
      Respiratory system: 
      Abdomen: 
      Central Nervous system: 
      Spine examination: 
Diagnosis: 
Surgery being performed: 
Investigations: 
ASA status: 
IV access: 
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Monitors: 
Pre medication: 
Group: 
VAS score during Positioning; 
Quality of patient positioning: 
0-Not satisfactory 
1-Satisfactory 
2-Good 
3-Optimal 
Time taken to perform Spinal Anaesthesia: 
Patient satisfaction: 
      1-   Satisfactory 
      2 -  Not satisfactory 
Hemodynamics: 
PARAMETERS 
BEFORE 
FICB/FENT 
5 MIN 10 MIN 15 MIN 
Heart Rate     
Blood Pressure     
SpO2     
Respiratory Rate     
 
Duration of surgery: 
First Rescue Analgesic:        
Complications : 
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PATIENT CONSENT FORM 
STUDY:   “COMPARATIVE EVALUATION OF FASCIA ILIACA 
COMPARTMENT BLOCK AND INTRAVENOUS FENTANYL FOR 
POSITIONING DURING SPINAL ANAESTHESIA IN FRACTURE FEMUR 
SURGERIES – A RANDOMIZED CONTROLLED STUDY”. 
STUDY CENTRE:GOVT. KILPAUK MEDICAL COLLEGE HOSPITAL & GOVT 
ROYAPETTAH  HOSPITAL, CHENNAI 
PATIENT’S NAME  :                                      PATIENT’S AGE:        I.P NO :                     
Patient may check ( √   ) these boxes 
I confirm that I understood the purpose of the procedure for the 
above study. I have the opportunity to ask questions and all my 
questions and doubts have been answered to my complete 
satisfaction. 
I understand that my participation in the study is purely 
voluntary and that I am free to withdraw at any time without 
giving reason, without my legal rights being affected. 
I understand that the Ethics Committee members and the 
regulatory authorities will not need my permission to look at my 
health records, both in respect of the current study and any 
further research that may be conducted in relation to it, even if I 
withdraw from the study I agree to this access. However, I 
understand that my identity will not be revealed in any 
information released to third parties or published, unless as 
required under the law.  
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I agree not to restrict the use of any data or results that arise 
from the study. I agree to take part in the above study and to 
comply with the instructions given during the study and 
faithfully cooperate with the study team and to immediately 
inform the study staff if I suffer from any deterioration in my 
health or wellbeing or any unexpected or unusual symptoms. 
I hereby consent to participate in this study. 
I hereby give permission to undergo complete clinical 
examination and diagnostic tests including hematological, 
biochemical, radiological tests. 
 
Signature / thumb impression:                              
 
Patient’s name and address:    place:  date: 
 
Signature of the investigator: 
 
Study investigator’s name:     place:  date: 
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சுய ஒப்புதல் படிவம் 
ஆய்வு செய்யப்படும் தலைப்பு: 
                                  
                                       
                                   
                     . 
         :        மருத்துவ துறை, 
        மருத்துவக்கல்லூரி  
அரசு மருத்துவமறை, சென்றை-10. 
 
பங்கு சபறுபவரின் சபயர்:        உறவு முலற: 
பங்கு சபறுபவரின் எண்: 
பங்கு சபறுபவர் இதலை (√) குறிக்கவும்: 
மமமே குைிப்பிட்டுள்ள மருத்துவ ஆய்வின் 
விவரங்கள் எைக்கு விளக்கப்பட்டது. என்னுறடய 
ெந்மேகங்கறளக் மகட்கவும், அேற்காை ேகுந்ே 
விளக்கங்கறளப் சபைவும் வாய்ப்பளிக்கப்பட்டது.  
நான் இவ்வாய்வில் ேன்ைிச்றெயாகத்ோன் 
பங்மகற்கிமைன். எந்ே காரணத்ேிைாமோ எந்ே கட்டத்ேிலும் 
எந்ே ெட்ட ெிக்கலுக்கும் உட்படாமல் நான் இவ்வாய்வில் 
இருந்து விேகிக் சகாள்ளோம் என்றும் அைிந்து 
சகாண்மடன். 
இந்ே ஆய்வு ெம்மந்ேமாகவும், மமலும் இது 
ொர்ந்ேஆய்வு மமற்சகாள்ளும்மபாதும், இந்ே ஆய்வில் 
பங்குசபறும் மருத்துவர் என்னுறடய மருத்துவ 
அைிக்றககறளப் பார்ப்பேற்கு என் அனுமேி 
மேறவயில்றே எை அைிந்துசகாள்கிமைன். நான் ஆய்வில் 
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இருந்து விேகிக் சகாண்டாலும் இது சபாருந்தும் எை 
அைிகிமைன். 
இந்ே ஆய்வின் மூேம் கிறடக்கும் ேகவல்கறளயும், 
பரிமொேறை முடிவுகறளயும் மற்றும் ெிகிச்றெ 
சோடர்பாை ேகவல்கறளயும் மருத்துவர் மமற்சகாள்ளும் 
ஆய்வில் பயன்படுத்ேிசகாள்ளவும், அறே பிரசுரிக்கவும் 
என் முழு மைதுடன் ெம்மேிக்கிமைன். 
இந்ே ஆய்வில் பங்கு சகாள்ள ஒப்புக்சகாள்கிமைன். 
எைக்கு சகாடுக்கப்பட்ட அைிவுறரகளின் படி 
நடந்துசகாள்வதுடன், இந்ே ஆய்றவ மமற்சகாள்ளும் 
மருத்துவ அணிக்கு உண்றமயுடன் இருப்மபன் என்றும் 
உறுேியளிக்கிமைன். என் உடல் நேம் பாேிக்கப்பட்டாமோ 
அல்ேது எேிர்பாராே வழக்கத்ேிற்கு மாைாக மநாய்க்குைி 
சேன்பட்டாமோ உடமை அறே மருத்துவ அணியிடம் 
சேரிவிப்மபன் எை உறுேி அளிக்கிமைன். 
 
    …   பங்மகற்பவரின் சபயர் மற்றும்       
       ….…………………………………………………………………………….. 
. ………….............................................                                                                                       
……………………………………….. 
 
பங்மகற்பவரின் றகசயாப்பம்/                                                           
கட்றடவிரல் மரறக:……… 
 
 
    …                    ஆய்வாளரின் றகசயாப்பம்……….. 
    ….                     ஆய்வாளரின்சபயர்………………. 
 
 
 
111 
 
 
 
 
 
 
 
 
 
 
 
 
 
MASTER CHART 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
112 
 
ANNEXURE TO MASTER CHART 
VISUAL ANALOGUE SCALE SCORE:  
 
QUALITY OF PATIENT POSITIONING: 
            0-Not satisfactory 
             1-Satisfactory 
             2-Good                   
             3-Optimal 
PATIENT SATISFACTION : 
1- Satisfactory   
2- Not satisfactory 
 
S.NO NAME AGE SEX WEIGHT IP. NO FRACTURE SITE
NO OF
 DAYS SINCE 
FRACTURE
VAS 
DURING 
POSITIONING
QUALITY 
OF PATIENT
 POSITIONING
PATIENT 
SATISFACTION
TIME 
TO PERFORM 
SAB (MIN)
H.R
 BEFORE
 BLOCK
H.R @ 
5MIN
H.R. @
 10 MIN
1 DAVID 24 M 60 21454 SHAFT OF FEMUR 5 0 3 1 4.15 96 94 95
2 RAJINI 37 M 58 22196 INTER TROCHANTER 7 0 3 1 4.3 92 94 95
3 RAJAMMAL 50 F 59 23710 NECK OF FEMUR 4 4 1 1 5.45 89 87 85
4 YASODHA 50 F 55 23607 NECK OF FEMUR 2 2 2 1 5.3 72 75 77
5 NEERADHA 54 F 53 21238 NECK OF FEMUR 6 2 2 1 6 81 84 84
6 KOTI 54 M 57 20761 INTER TROCHANTER 4 0 3 1 5 80 79 81
7 PRAKASH 48 M 65 24522 NECK OF FEMUR 3 2 2 1 4.45 83 85 82
8 JAYASINGH 34 M 69 23288 SUB TROCHANTER 2 0 3 1 4 102 102 100
9 SHEIKH MOHAMMED 41 M 60 22750 SUB TROCHANTER 4 2 2 1 4.3 84 82 81
10 RAGHUNATHAN 48 M 65 24886 INTER TROCHANTER 3 2 2 1 4.4 79 81 80
11 MOHAN KUMAR 30 M 70 22912 SHAFT OF FEMUR 3 0 3 1 4.15 70 72 69
12 ARUNACHALAM 54 M 67 23527 INTER TROCHANTER 5 2 2 1 5.3 87 85 86
13 PANDIYAN 47 M 70 24759 SUB TROCHANTER 4 0 3 1 4.45 89 91 80
14 SIVAJI 54 M 66 23238 INTER TROCHANTER 6 0 3 1 5 86 83 83
15 MANICKAM 55 M 63 24615 NECK OF FEMUR 3 2 2 1 5.3 92 93 95
16 AGAVALLI 53 F 59 23915 INTER TROCHANTER 6 0 3 1 5.15 95 93 92
17 JAGAN 23 M 67 24219 SHAFT OF FEMUR 3 2 2 1 4.15 105 102 100
18 MEENA 50 F 57 25415 NECK OF FEMUR 5 0 3 1 5.15 79 81 79
19 SHEKHAR 53 M 68 24281 INTER TROCHANTER 4 0 3 1 5.2 85 86 87
20 RAMRAJ 28 M 70 24976 SHAFT OF FEMUR 3 2 2 1 4.3 99 102 103
21 NAGAMMAL 52 F 55 25404 NECK OF FEMUR 6 2 2 1 5.3 81 83 82
22 KAVITHA 54 F 60 26963 INTER TROCHANTER 6 0 3 1 5 75 76 76
23 ADHIAMMAL 50 F 59 25848 NECK OF FEMUR 5 2 2 1 5.15 87 88 89
24 ETHIRAJ 55 M 67 25198 INTER TROCHANTER 7 0 3 1 5 94 96 95
25 PARVATHY 55 F 56 26004 NECK OF FEMUR 4 2 2 1 5.3 91 92 91
26 ANANDIYAMMAL 52 F 59 26951 INTER TROCHANTER 6 0 3 1 5.45 85 86 83
27 SARADHA 55 F 61 25114 NECK OF FEMUR 7 2 2 1 5 79 81 80
28 ANANDHAN 53 M 69 26129 INTER TROCHANTER 6 4 1 2 6 78 82 83
29 RAM BABU 22 M 71 26816 SHAFT OF FEMUR 3 0 3 1 4.3 95 96 94
30 DANIEL 47 M 68 25181 INTER TROCHANTER 4 0 3 1 5 98 99 100
GROUP FICB
H.R. @ 
15 MIN 
(DURING 
POSITIONING)
MAP 
BEFORE 
THE BLOCK
MAP @
 5 MIN
MAP @ 
10 MIN
MAP @ 
15 MIN 
(DURING
 POSITIONING)
SPO2 
BEFORE 
BLOCK
SPO2 
@ 5 MIN
SPO2 
@ 10 MIN
SPO2 @ 
15 MIN
 (DURING 
POSITIONING)
R.R. 
BEFORE
 BLOCK
R.R. 
@ 5 MIN
R.R. @ 
10 MIN
R.R. @ 15 MIN
 (DURING
 POSITIONING)
FIRST 
RESCUE 
ANALGESIC 
POSTOP (hrs)
94 101 97 96 94 98 99 99 99 18 17 18 18 6
94 107 106 102 104 98 99 99 100 16 18 17 16 9
84 99 95 93 92 98 98 99 100 17 18 18 17 6
73 93 95 99 99 97 98 99 99 19 18 18 16 6.3
82 105 107 103 105 97 98 98 98 18 18 17 17 6
82 91 98 97 95 98 98 99 99 20 18 17 17 6.3
81 91 89 90 91 99 99 99 99 15 16 16 17 5.3
101 95 96 98 95 99 99 100 99 15 15 16 14 6
80 102 104 104 101 98 99 100 99 14 14 15 14 5
79 106 102 104 101 99 100 99 100 17 17 17 16 6
69 90 92 93 92 100 100 99 100 19 19 18 17 5
85 93 98 91 89 98 98 99 99 18 19 18 18 5.3
81 90 93 89 91 98 99 100 99 18 18 17 17 6.3
82 98 96 91 93 97 98 99 99 17 17 16 16 5.3
94 114 110 107 108 98 99 100 99 18 18 16 17 6
90 100 98 95 93 98 99 99 100 18 17 17 18 6
101 96 99 97 98 99 100 100 100 17 18 18 17 5.3
80 106 109 108 105 98 99 98 99 19 19 18 18 6
86 110 107 106 103 97 98 99 99 17 18 18 16 7
99 91 93 95 96 99 99 100 100 18 18 18 17 6
84 102 98 94 92 98 99 98 99 17 17 17 18 6.3
74 106 105 103 101 97 98 99 99 16 16 17 16 6
90 116 111 110 108 98 98 99 99 16 16 17 17 6
94 101 105 104 106 98 99 99 100 17 16 16 15 4.3
90 107 104 102 100 97 98 98 99 18 18 17 17 5.3
84 91 94 90 92 98 98 99 99 17 17 16 16 6
78 103 100 98 99 97 98 99 99 18 17 17 16 6.3
81 108 104 102 101 98 99 100 99 20 19 19 19 5.3
93 95 92 90 92 99 99 100 100 17 18 18 17 6
99 98 98 95 96 98 100 99 99 18 18 18 17 5.3
GROUP FICB
S.NO NAME AGE SEX WEIGHT IP. NO FRACTURE SITE
NO. OF 
DAYS SINCE 
FRACTURE
VAS 
DURING
POSITIONING
QUALITY 
OF PATIENT
 POSITIONING
PATIENT 
SATISFACTION
TIME TO 
PERFORM 
SAB (MIN)
H.R 
BEFORE 
BLOCK
H.R 
@5MIN
1 MUNIYAMMAL 53 F 56 20517 NECK OF FEMUR 5 4 1 2 7 96 92
2 SATHISH 30 M 69 22976 SHAFT OF FEMUR 2 2 2 1 4.45 86 82
3 ANGAMMAL 55 F 58 21365 INTER TROCHANTER 6 4 1 2 6.3 81 78
4 KUPPUSAMY 54 M 59 23996 NECK OF FEMUR 4 2 2 1 5.3 93 91
5 DAVID RAJ 45 M 69 20189  SUB TROCHANTER 5 2 2 1 5.45 78 75
6 HONEST RAJ 26 M 64 21921 SHAFT OF FEMUR 2 2 2 1 5.2 80 77
7 INDRANI 48 F 65 20838 INTER TROCHANTER 4 2 2 1 6 85 82
8 GANDHIMATHI 55 F 60 22453 NECK OF FEMUR 8 4 1 2 7.15 88 89
9 RAJESHWARI 47 F 58 21563 INTER TROCHANTER 6 2 2 1 6 91 88
10 RANGANATHAN 46 M 72 22654 INTER TROCHANTER 5 0 3 1 5.3 87 82
11 JEYAGOPAL 52 M 68 23162 NECK OF FEMUR 7 2 2 1 5.5 78 75
12 VEERARAGHAVAN 47 M 73 21112 INTER TROCHANTER 6 2 2 1 6.15 89 83
13 VALLI 51 F 56 22873 NECK OF FEMUR 6 0 3 1 5.3 86 82
14 PERIYASAMY 45 M 65 22405 INTER TROCHANTER 4 6 0 2 6.45 99 95
15 PREM KUMAR 32 M 68 23167 INTER TROCHANTER 3 2 2 1 5 79 80
16 SHANTHY 45 F 57 22728 NECK OF FEMUR 5 2 2 1 6 100 96
17 MUTHU KUMAR 37 M 68 23080 SUB TROCHANTER 3 2 2 1 5.2 82 80
18 KASINATHAN 52 M 60 24542 NECK OF FEMUR 5 4 1 2 7.15 95 93
19 SELVARANI 53 F 55 23954 NECK OF FEMUR 6 6 0 2 8 92 88
20 VENKATESAN 55 M 63 24126 NECK OF FEMUR 5 2 2 1 6.3 89 85
21 CHELLAMMAL 55 F 56 24149 HEAD OF FEMUR 7 2 2 1 6.2 105 100
22 KASTHURI 54 F 58 23789 INTER TROCHANTER 6 2 2 1 7 88 86
23 MOORTHY 42 M 67 23828 NECK OF FEMUR 3 2 2 1 5.45 91 87
24 VIKRAM 23 M 63 23856 SHAFT OF FEMUR 2 0 3 1 4.45 100 98
25 MOHAN 53 M 65 25616 INTER TROCHANTER 5 2 2 1 5.3 79 75
26 RAVI 42 M 64 25812 SUB TROCHANTER 4 0 3 1 5.45 84 83
27 RAJAPANDIAN 48 M 61 25903 INTER TROCHANTER 4 2 2 1 6 90 88
28 MURUGESAN 50 M 66 26183 NECK OF FEMUR 5 2 2 1 6.15 87 84
29 KRISHNAN 41 M 65 26215 HEAD OF FEMUR 3 4 1 2 5.45 102 98
30 ANAND 30 M 68 26739 SHAFT OF FEMUR 4 0 3 1 5.1 81 77
GROUP FENT
H.R. @
 10 MIN
H.R. @ 
15 MIN
 (DURING 
POSITIONING)
MAP 
BEFORE 
THE BLOCK
MAP @
 5 MIN
MAP @
 10 MIN
MAP @ 
15 MIN 
(DURING
 POSITIONING)
SPO2
 BEFORE
 BLOCK
SPO2 @ 
5 MIN
SPO2 @ 
10 MIN
SPO2 @ 
15 MIN 
(DURING 
POSITIONING)
R.R. 
BEFORE 
BLOCK
R.R. @
 5 MIN
R.R. @ 
10 MIN
R.R. @ 
15 MIN 
(DURING
 POSITIONING)
FIRST 
RESCUE 
ANALGESIC
 POST OP 
(hrs)
88 86 98 100 97 96 97 99 99 99 18 17 15 14 3
80 76 90 92 88 87 99 99 100 100 18 17 16 16 1.5
76 72 102 100 100 98 98 99 99 98 17 16 15 13 1.5
86 82 105 102 100 97 98 98 99 99 16 16 15 14 2
71 69 90 89 90 88 99 99 100 100 19 17 16 16 1
72 70 95 93 90 91 99 100 100 100 17 18 16 16 1.5
78 73 118 114 112 110 98 98 99 99 17 17 16 14 2
85 82 107 106 104 102 97 98 99 98 16 15 14 12 3
84 81 103 100 101 102 98 99 99 98 17 16 14 13 1.5
80 79 99 97 98 96 98 99 99 99 16 14 14 13 1.5
71 68 108 105 103 102 99 99 100 100 18 17 16 15 2.5
80 78 98 99 96 95 98 99 99 98 17 17 16 15 1.5
90 88 102 100 99 97 97 98 98 97 16 14 13 12 2
92 90 110 108 104 103 98 99 99 99 19 17 16 17 2
74 70 92 90 91 92 99 100 100 99 17 17 17 15 1.5
92 88 99 97 97 95 98 99 100 98 18 17 16 14 2
77 75 98 95 94 92 99 100 100 99 17 16 16 15 1.5
88 86 103 105 102 101 97 99 99 98 18 18 16 15 2
85 90 115 111 108 111 97 98 98 97 17 16 16 16 2
81 79 102 100 100 98 98 99 98 98 19 18 18 16 2
96 90 105 102 99 101 97 98 98 97 17 15 13 12 1.5
81 78 110 106 104 102 98 99 98 98 16 16 14 12 0.5
84 81 99 102 100 98 99 98 99 98 18 18 17 17 1
92 88 96 98 94 93 99 100 100 100 19 18 17 16 0.5
72 71 98 102 99 97 98 99 100 99 17 17 16 15 1
81 78 108 105 103 104 99 99 99 99 17 17 15 14 1.5
85 81 99 98 101 97 98 100 99 98 18 18 16 14 1
80 78 109 106 105 104 97 99 99 98 16 16 16 15 2
95 91 102 104 100 100 98 99 99 99 17 17 16 15 2
75 72 96 98 97 96 99 100 100 99 18 18 16 16 1
GROUP FENT
